Automatic scheduling

Notwithstanding any law to the contrary, any pharmaceutical composition of crystalline polymorph psilocybin that is approved by the United States Food and Drug Administration and is then scheduled by the United States Drug Enforcement Administration shall be automatically scheduled on the corresponding state schedule in Sections 41-29-113 through 41-29-121 and shall be subject to the fines and penalties of that state schedule. This automatic scheduling shall be effective from the date that the drug is designated on the federal schedule until the effective date of legislation amending the corresponding state schedule or until the conclusion of the next regular session of the Legislature, including the time period in which the bill is subject to veto by the governor, whichever is earlier.